FdaApplication
NDA 021332
Identifiers
- fda_app_no: NDA021332
Properties
| Property | Value |
|---|---|
| applicant_name | ASTRAZENECA AB |
| application_type | NDA |
| approval_date | 2005-03-16 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SYMLIN | PRAMLINTIDE ACETATE | EQ 2.7MG BASE/2.7ML (EQ 1MG BASE/ML) | INJECTABLE;SUBCUTANEOUS |
| SYMLIN | PRAMLINTIDE ACETATE | EQ 3MG BASE/5ML (EQ 600MCG BASE/ML) | INJECTABLE;SUBCUTANEOUS |
| SYMLIN | PRAMLINTIDE ACETATE | EQ 1.5MG BASE/1.5ML (EQ 1MG BASE/ML) | INJECTABLE;SUBCUTANEOUS |
3 products